review Open AccessTop 1% cited

Industry sponsorship and research outcome

Cochrane Database of Systematic Reviews · 2017 · Vol. 2017(2) · pp. MR000033–MR000033

Andreas Lundh✉(University of Southern Denmark)Joel Lexchin(York University)Barbara Mintzes(University of Sydney)Jeppe Bennekou Schroll(Herlev Hospital)Lisa Bero(University of Sydney)

View via DOI Full-text PDF

Abstract

Sponsorship of drug and device studies by the manufacturing company leads to more favorable efficacy results and conclusions than sponsorship by other sources. Our analyses suggest the existence of an industry bias that cannot be explained by standard 'Risk of bias' assessments.

Pharmaceutical industry and healthcare scientometrics and bibliometrics research Academic Writing and PublishingOutcome (game theory)BusinessEconomics

MeSH terms

Data Interpretation, StatisticalDrug IndustryEquipment and SuppliesIndustryResearch Support as TopicConflict of InterestTreatment OutcomePublication BiasResearch Report

Citations

1,567

FWCI

158.46

field-weighted impact

References

318

Percentile

100%

vs. same field & year

Citations per year

Cited by